Press Releases
- Active Biotech AB Interim report January - September 2014 November 5, 2014 08:34 (CET)
- Active Biotech AB: Notice of Extraordinary General Meeting of Shareholders November 5, 2014 08:32 (CET)
- Active Biotech strengthens its financial position: rights issue of approximately SEK 225 million November 5, 2014 08:31 (CET)
- Active Biotech AB Interim report January - September 2014 November 5, 2014 08:30 (CET)
- Teva and Active Biotech Announce Expansion of Laquinimod Clinical Development Program with New Trial in Primary Progressive Multiple Sclerosis and First Patient Screened in Huntington's Disease Trial November 4, 2014 14:00 (CET)
- Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More Years at Joint ACTRIMS-ECTRIMS Meeting September 12, 2014 14:00 (CEST)
- Active Biotech's partner Teva initiates a laquinimod clinical trial in Huntington's disease August 14, 2014 08:36 (CEST)
- Active Biotech's partner Teva initiates a laquinimod clinical trial in Huntington's disease August 14, 2014 08:30 (CEST)
- Active Biotech AB Interim report January-June 2014 August 7, 2014 08:36 (CEST)
- Active Biotech AB Interim report January-June 2014 August 7, 2014 08:30 (CEST)